Roche’s leadership shuffle, which began in July, continued on Monday with the departure of pharma sector CEO Bill Anderson. , Roche’s leadership shuffle, which began in July, continued on Monday with the departure of pharma sector CEO Bill Anderson, who took over in 2019. But this year, the sector’s fortunes declined with several clinical setbacks. Anderson is leaving at the end of this year to “pursue other opportunities,” the company said in a release.
